Misdiagnosis analysis and multidisciplinary collaborative treatment of primary cutaneous diffuse large B-cell lymphoma: case report - Report - MDSpire

Misdiagnosis analysis and multidisciplinary collaborative treatment of primary cutaneous diffuse large B-cell lymphoma: case report

  • By

  • Hongjuan Ji

  • Qiao Zhang

  • Gaowei Zhang

  • Hongli Ji

  • Lei Zhao

  • June 26, 2026

  • 0 min

Share

Clinical Report: Misdiagnosis and Management in Primary Cutaneous DLBCL

Overview

This case study highlights the frequent misdiagnosis of primary cutaneous diffuse large B-cell lymphoma (PC-DLBCL) in an elderly patient. The patient underwent treatment involving orthopedic debridement and R-miniCHOP immunochemotherapy, resulting in complete resolution of skin lesions.

Background

Primary cutaneous diffuse large B-cell lymphoma (PC-DLBCL) is a rare and aggressive form of non-Hodgkin lymphoma that often presents with nonspecific skin symptoms, leading to misdiagnosis. This condition primarily affects elderly patients, who may experience severe complications due to delayed treatment.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • PC-DLBCL is frequently misdiagnosed due to its nonspecific cutaneous manifestations.
  • The patient was initially misdiagnosed with skin allergy, skin cancer, and pemphigus.
  • Multidisciplinary management involving orthopedic and hematology-oncology specialists was essential for effective treatment.
  • The patient underwent orthopedic debridement, autologous skin grafting, and R-miniCHOP immunochemotherapy.
  • Complete resolution of skin lesions was achieved without recurrence at 7-month follow-up.

Clinical Implications

Early pathological biopsy is critical for accurate diagnosis of PC-DLBCL. Collaborative care between specialties is essential for effective treatment.

Conclusion

This case underscores the importance of recognizing PC-DLBCL to prevent misdiagnosis and ensure timely, effective treatment through multidisciplinary collaboration.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Primary diffuse large b-cell lymphoma of the lip: a case report and literature review
  2. Blood Cancer Journal, 2025 -- Macrophages Expressing PDL1 Infiltrate Diffuse Large B-Cell Lymphoma and Enhance Tumor Growth in a MYC-Driven Experimental Model
  3. Temple Health -- Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient
  4. Blood Cancer Journal, 2025 -- Outcomes of Treatment and Risk of CNS Relapse in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type During the Rituximab Era
  5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  6. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group - ScienceDirect
  7. Entity and biology of PC-DLBCL
  8. Guidance on management of cutaneous lymphomas
  9. Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era

Original Source(s)

Related Content